Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

BUY
$27.42 - $43.63 $80,669 - $128,359
2,942 New
2,942 $91,000
Q3 2021

Oct 18, 2021

SELL
$50.07 - $66.05 $69,947 - $92,271
-1,397 Closed
0 $0
Q2 2021

Aug 02, 2021

BUY
$56.61 - $80.46 $79,084 - $112,402
1,397 New
1,397 $88,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $515M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Islay Capital Management, LLC Portfolio

Follow Islay Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Islay Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Islay Capital Management, LLC with notifications on news.